Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Clinical presentation, diagnosis and staging of cholangiocarcinoma
Alejandro Forner, Gianpaolo Vidili, Marco Rengo, et al.
Liver International (2019) Vol. 39, Iss. S1, pp. 98-107
Open Access | Times Cited: 252

Showing 26-50 of 252 citing articles:

Liquid biopsy in cholangiocarcinoma: Current status and future perspectives
Gianluca Rompianesi, Marcello Di Martino, Alex Gordon‐Weeks, et al.
World Journal of Gastrointestinal Oncology (2021) Vol. 13, Iss. 5, pp. 332-350
Open Access | Times Cited: 44
Molecular profiling in cholangiocarcinoma: A practical guide to next-generation sequencing
Albrecht Stenzinger, Arndt Vogel, Ulrich Lehmann, et al.
Cancer Treatment Reviews (2023) Vol. 122, pp. 102649-102649
Open Access | Times Cited: 19
Unresectable biliary tract cancer: Current and future systemic therapy
Danmei Zhang, Klara Dorman, C. Benedikt Westphalen, et al.
European Journal of Cancer (2024) Vol. 203, pp. 114046-114046
Open Access | Times Cited: 8
Combined immune checkpoint inhibition with durvalumab and tremelimumab with and without radiofrequency ablation in patients with advanced biliary tract carcinoma
Cecilia Monge, Changqing Xie, Yuta Myojin, et al.
Cancer Medicine (2024) Vol. 13, Iss. 3
Open Access | Times Cited: 7
Lymphocyte‐C‐reactive protein ratio as a novel prognostic index in intrahepatic cholangiocarcinoma: A multicentre cohort study
Lianghe Lu, Chong Zhong, Wei Wei, et al.
Liver International (2020) Vol. 41, Iss. 2, pp. 378-387
Closed Access | Times Cited: 49
Mitogen-Activated Protein Kinases (MAPKs) and Cholangiocarcinoma: The Missing Link
Chaobo Chen, Leonard J. Nelson, Matías A. Ávila, et al.
Cells (2019) Vol. 8, Iss. 10, pp. 1172-1172
Open Access | Times Cited: 47
Molecular and Immunological Characterization of Biliary Tract Cancers: A Paradigm Shift Towards a Personalized Medicine
Ines Malenica, Matteo Donadon, Ana Lleò
Cancers (2020) Vol. 12, Iss. 8, pp. 2190-2190
Open Access | Times Cited: 44
Application of photodynamic therapy for liver malignancies
Heng Zou, Fusheng Wang, Jiangjiao Zhou, et al.
Journal of Gastrointestinal Oncology (2020) Vol. 11, Iss. 2, pp. 431-442
Open Access | Times Cited: 40
Brush Cytology, Forceps Biopsy, or Endoscopic Ultrasound-Guided Sampling for Diagnosis of Bile Duct Cancer: A Meta-Analysis
Seung Bae Yoon, Sung‐Hoon Moon, Sung Woo Ko, et al.
Digestive Diseases and Sciences (2021) Vol. 67, Iss. 7, pp. 3284-3297
Closed Access | Times Cited: 38
Immunotherapy in Advanced Biliary Tract Cancers
Alice Boilève, Marc Hilmi, Cristina Smolenschi, et al.
Cancers (2021) Vol. 13, Iss. 7, pp. 1569-1569
Open Access | Times Cited: 33
Potential influence of the microbiome environment in patients with biliary tract cancer and implications for therapy
Roseanna Wheatley, Elaine Kilgour, Timothy W. Jacobs, et al.
British Journal of Cancer (2021) Vol. 126, Iss. 5, pp. 693-705
Open Access | Times Cited: 33
Changing Landscape of Systemic Therapy in Biliary Tract Cancer
Edward Woods, Dat Tan Le, Bharath Kumar Jakka, et al.
Cancers (2022) Vol. 14, Iss. 9, pp. 2137-2137
Open Access | Times Cited: 28
Integrating cytotoxic, targeted and immune therapies for cholangiocarcinoma
Joachim Merters, Ángela Lamarca
Journal of Hepatology (2022) Vol. 78, Iss. 3, pp. 652-657
Open Access | Times Cited: 26
Role of molecular genetics in the clinical management of cholangiocarcinoma
Nicola Normanno, Erika Martinelli, Davide Melisi, et al.
ESMO Open (2022) Vol. 7, Iss. 3, pp. 100505-100505
Open Access | Times Cited: 25
Radiomics-Based Preoperative Prediction of Lymph Node Metastasis in Intrahepatic Cholangiocarcinoma Using Contrast-Enhanced Computed Tomography
Shuaitong Zhang, Shengyu Huang, Wei He, et al.
Annals of Surgical Oncology (2022) Vol. 29, Iss. 11, pp. 6786-6799
Closed Access | Times Cited: 24
Cholangiocarcinoma: Pathologic and Molecular Classification in the Era of Precision Medicine
Purva Gopal, Marie E. Robert, Xuchen Zhang
Archives of Pathology & Laboratory Medicine (2023) Vol. 148, Iss. 3, pp. 359-370
Open Access | Times Cited: 16
A CT-based radiomics approach to predict intra-tumoral tertiary lymphoid structures and recurrence of intrahepatic cholangiocarcinoma
Ying Xü, Zhuo Li, Yi Yang, et al.
Insights into Imaging (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 15
Clinical prospective study of Gallium 68 (68Ga)–labeled fibroblast-activation protein inhibitor PET/CT in the diagnosis of biliary tract carcinoma
Jinghua Li, Kui Xu, Deliang Guo, et al.
European Journal of Nuclear Medicine and Molecular Imaging (2023) Vol. 50, Iss. 7, pp. 2152-2166
Open Access | Times Cited: 14
Advances in immunotherapy for biliary tract cancers
Yuhao Zhao, Mao Yang, Jiayi Feng, et al.
Chinese Medical Journal (2023) Vol. 137, Iss. 5, pp. 524-532
Open Access | Times Cited: 14
Update on the Screening, Diagnosis, and Management of Cholangiocarcinoma.
Sudha Kodali, Ashton A. Connor, Elizabeth W. Brombosz, et al.
PubMed (2024) Vol. 20, Iss. 3, pp. 151-158
Closed Access | Times Cited: 5
Biliary Tract Cancers: Molecular Heterogeneity and New Treatment Options
Nicola Personeni, Ana Lleò, Tiziana Pressiani, et al.
Cancers (2020) Vol. 12, Iss. 11, pp. 3370-3370
Open Access | Times Cited: 36
Immunotherapy for the treatment of biliary tract cancer: an evolving landscape
H. Catherine Wilbur, Nilofer S. Azad
Therapeutic Advances in Medical Oncology (2024) Vol. 16
Open Access | Times Cited: 4
Clinical care pathways of patients with biliary tract cancer: A French nationwide longitudinal cohort study
Stylianos Tzedakis, Alexandre Challine, Sandrine Katsahian, et al.
European Journal of Cancer (2024) Vol. 202, pp. 114018-114018
Closed Access | Times Cited: 4
Overcoming Resistance to Immune Checkpoint Blockade in Liver Cancer with Combination Therapy: Stronger Together?
Wiebke Werner, Maria Kuzminskaya, Isabella Lurje, et al.
Seminars in Liver Disease (2024) Vol. 44, Iss. 02, pp. 159-179
Open Access | Times Cited: 4
Prediction of survival after pancreatoduodenectomy for distal cholangiocarcinoma: independent external validation of a prognostic model for 3-year overall survival in Sweden
Johannes Byrling, Bodil Andersson
Scandinavian Journal of Gastroenterology (2025), pp. 1-7
Open Access

Scroll to top